02359.HK
WuXi AppTec Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 191.10
−0.57%Year over year
Reported trailing growth
- Revenue
- +24.9%
- EBITDA
- +54.1%
- EBIT
- +39.7%
- EPS
- +56.3%
- Free cash flow
- +28.6%
- Operating cash flow
- +31.9%
Forward estimates
Based on analyst estimates
- Revenue
- +21.5%
- EBITDA
- +20.3%
- EPS
- +1.8%
Three-year CAGR
- Revenue
- +4.9%
- EBITDA
- +30.6%
- EBIT
- +16.9%
- Net income
- +29.5%
- EPS
- +28.6%
- Free cash flow
- +161.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026